Go Back / Location：Home / Application

MGI Asia Pacific Pandemic Preparedness Program (PPP)

Empowering pathogen surveillance across the region

The MGI Asia Pacific (APAC) Pandemic Preparedness Program (PPP) is designed to equip institutions and laboratories across the Asia Pacific region, with plans for global expansion, with advanced pathogen surveillance and response solutions.

Born out of collaborations with key stakeholders, including the Asia Pathogen Genomics Initiative (APGI), the program delivers sustainable and impactful solutions for acute infectious disease surveillance. It focuses on delivering application-driven workflows that address pathogen genomics in an equitable, effective, and validated manner.

Program benefits

	Special discounts on selected sequencing instruments, consumables, and application packages for eligible organizations, ensuring cost-efficiency
	Preconfigured application bundles covering library preparation, sequencing, and data analysis, designed for infectious disease genomic surveillance
	No minimum order requirements, offering versatile purchasing terms

Who can apply?

This program is tailored for universities, government institutes, hospitals, and research institutions that are focused on pathogen genomic surveillance. By providing access to tailored solutions, it ensures institutions can achieve timely, accurate, and actionable genomic insights.

The collaboration with APGI and its country partners marks a crucial step in expanding the reach of pathogen genomics. The program will soon extend to other institutions looking to develop or enhance their surveillance capabilities.

PPP application bundles

MGI offers transparent and cost-effective pricing on reagents and sequencing instruments through specialized pandemic preparedness application bundles. These bundles include all necessary reagents, consumables, and equipment for a full sample-to-answer workflow.

Eligible PPP recipients can access the following preconfigured Application Bundles (see table below) designed for various genomic surveillance needs. These bundles combine discounted rates on library preparation, sequencing, and analysis, with extraction costs included, according to product validation protocols.

Category	Application	MGI Product Package	Usage
Shotgun Metagenomic Sequencing (mNGS)	Metagenomics Genomic Surveillance	Human Microbiome Metagenomics Sequencing Package	In-depth profiling and novel pathogen detection across the entire genetic repertoire of organisms for unknown/uncharacterized community samples.
Shotgun Metagenomic Sequencing (mNGS)	Vector Species and Pathogen Identification	Vector and Microorganism Identification Package	Identification of vector species and/or pathogens they carry using primary samples, such as degraded and/or immature vector samples from extracted DNA and/or RNA.
Whole Genome Sequencing (WGS)	Epidemiology Investigation for Mycobacterium Tuberculosis (MTB) Drug Resistance	MTB Whole Genome Sequencing Package	Whole genome sequencing of DNA extracted from Mycobacterium tuberculosis cultured isolates and Drug-resistance prediction based on the WHO MTB mutation catalogue, as well as MTBC & NTM identification, spoligotype identification and evolutionary analysis.
Targeted Sequencing (tNGS)	Rapid Identification of Mycobacterium Tuberculosis (MTB) Drug Resistance	ATOPlex MTB Sequencing Package	Detection of Mycobacterium tuberculosis complex or cultured samples targeted drug resistance genes, identification of mixed Non-tuberculous Mycobacteria (NTM) species, and drug resistance prediction based on the WHO MTB mutation catalogue for first- and second-line anti-tuberculosis drugs using extracted genomic DNA.
	Human Immunodeficiency Virus (HIV-1) Drug Resistance	HIV-1 Drug Resistance Sequencing Products Package	Identification of HIV-1 virus genotype and targeted detection for drug resistance mutations in pol gene based on Stanford HIV Drug Resistance Database (HIVdb) and phylogenetic analysis using extracted total RNA from HIV-1 positive samples.
	SARS-CoV-2 Genomic Surveillance	SARS-CoV-2 Sequencing Package	Detection, clade identification, and phylogeny analysis of SARS-CoV-2 virus for single and mixed lineages using total RNA from wastewater, pharyngeal swabs, bronchoalveolar lavage fluid and other samples.
	Influenza A/B Genomic Surveillance	Respiratory Microbiome Genome Sequencing Package	Detection, assembly, subtype identification, and phylogenetic analysis of Influenza (A/B) virus using extracted total RNA from nasopharyngeal swabs.
	Monkeypox (MPXV) Genomic Surveillance	ATOPlex MPXV Sequencing Package	Detection, assembly, clade identification, and phylogenetic analysis of MPXV virus using extracted DNA from blister fluid or oropharyngeal swabs and nasal swabs.
	Dengue Virus (DENV1-4) Genomic Surveillance	ATOPlex DENV1-4 Sequencing Package	Detection, typing, clade identification and analysis of closely related genomes of DENV (1/2/3/4) using RNA extracted from plasma, serum and other samples.
	16S rDNA Characterization	Microbiome Metabarcoding Sequencing Package	Metagenomic survey of species-level identification, composition, and community structures of bacteria based on 16S rDNA using genomic DNA extracted from complex microbiome samples.
Pan-Pathogen and AMR Detection	Pan-Pathogen and Antimicrobial Resistance (AMR) Detection	Pan-Pathogen and Antimicrobial Resistance (AMR) Detection Package	Identification of 330 clinically relevant pathogens (bacteria, viruses, fungi, parasites) and 150 AMR genes using total nucleic acid extracted from various biospecimens.
Note: Subject to hardware dependencies, software configurations, and application-specific optimized workflows. Additional analysis software may be required, with alternatives evaluated based on project urgency and scope.

How to apply

If you're interested in participating in the MGI APAC PPP, please email the following information with the subject line "MGI APAC PPP Expression of Interest":

Name:

Phone:

Email:

Location:

Institution or Company:

Job Title:

What pathogen(s) are you interested in monitoring for surveillance?

[Your answer]

Do you currently have a workflow in place for pathogen surveillance? If yes, please describe it briefly.

[Your answer]

Approximate number of samples processed per month:

[Your answer]

Any additional questions or feedback for the MGI APAC PPP team:

[Your answer]

Do you have funding available for pathogen genomic surveillance purchases?

l Yes: both instruments and reagents

l Yes: instruments only

l Yes: reagents only

l No

Please direct submissions to the following addresses:

lihairui@mgi-tech.com
patrickmcloughlin@mgi-tech.com
shirley.guo@mgi-tech.com
lifangzhou@mgi-tech.com

*Disclaimer: The MGI APAC PPP is intended for public health surveillance and research purposes, with MGI retaining exclusive rights to modify, expand, or discontinue the program at its discretion.
**Program Availability: Currently, the PPP is available to countries in Southeast Asia (Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Myanmar, Cambodia, Laos, Brunei, Timor-Leste) and South Asia (India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, Maldives). If your country is not included in the list above, please contact us directly.